中心由国家发展改革委员会批准建设，平移后重点聚焦海洋生物活性物质开发利用、绿色制备技术及工艺、海洋药物和海洋健康产品等研发方向，旨在打造成为高水平的海洋生物制备技术平台，赋能海洋生物产业高质量发展。

Approved by the National Development and Reform Commission, the Center is now affiliated with Fujian-OI. It focuses on the development and utilization of marine bioactive substances, green biomanufacturing technologies, and marine pharmaceuticals and health products. The Center advances a high-level marine bioproduct engineering and technology platform to support the high-quality development of the marine bioproduct industry.

*平移支柱：依托原单位建设基础和深厚积淀， 
借助鹭江创新实验室体制机制优势，开展不重复、有增量的研究，实现价值提升和加速成果转化。